Port catheter complications and thrombosis issues: assessment of 114 patients with port catheter implantation by single surgeon
DOI:
https://doi.org/10.15419/bmrat.v4i12.401Keywords:
Chemotherapy, Port catheter, Port catheter embolism, Thromboembolism, ThrombosisAbstract
Background: We provided a comparative presentation of complications seen in 114 patients with port catheter implantation. In addition, we addressed whether patients with catheter-related thrombosis have distinctive features by assessing patients who developed thrombosis either at the catheter implant site or vascular bed.
Methods: In this study, we analyzed data from 114 patients who underwent subclavian venous port catheter implantation by a single surgeon at Kayseri Teaching Hospital (Turkey) during 2013 to 2016. Subclavian port catheter was inserted in all cases. The diagnosis of port thrombosis was made by Doppler sonography or thorax CT scan with contrast enhancement in patients presenting with edema at upper extremity, swelling or pain at neck, and/or dysfunctional port.
Results: Seroma was detected in only one case, lymphedema developed in one case (0.8%), and pneumothorax was observed in 3 cases. The subclavian vein was implanted on the right side in all patients with pneumothorax. None of these cases were associated with thrombosis. Port infection was observed in one case (0.8%). There was also one case (0.8%) of skin necrosis. The port was removed in 15 patients due to several reasons, which are indicated in Table 2. Thromboembolic events were observed in 11 of the 114 patients while port thrombosis was observed in 7 patients. The rate of hypertension in the thromboembolism group was 61.1% (11/18 individual) while the rate of hypertension in the group without thromboembolism was 28.1% (27/96 individuals); this difference was statistically significant (p = 0.006).
Conclusion: In this study, based on complications observed in patients with catheter-related thrombosis, factors such as smoking or diabetes mellitus were seen to be linked to thromboembolism and should be taken into consideration. Moreover, it was observed that hypertension had a significant association with thromboembolism.
References
Aziret, M., İrkörücü, O., Gökler, C., Reyhan, E., Çetinkünar, S., Çil, T., . . . Değer, K. C. (2015). Performance of venous port catheter insertion by a general surgeon: A prospective study. International Surgery, 100(5), 827–835. https://doi.org/10.9738/INTSURG-D-14-00214.1 PMID:26011202
Biffi, R., Orsi, F., Pozzi, S., Pace, U., Bonomo, G., Monfardini, L., . . . Goldhirsch, A. (2009). Best choice of central venous insertion site for the prevention of catheter-related complications in adult patients who need cancer therapy: A randomized trial. Annals of Oncology : Official Journal of the European Society for Medical Oncology, 20(5), 935–940. https://doi.org/10.1093/annonc/mdn701 PMID:19179550
Cesaro, S., Tridello, G., Cavaliere, M., Magagna, L., Gavin, P., Cusinato, R., . . . Carli, M. (2009). Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer. Journal of Clinical Oncology, 27(12), 2059–2065. https://doi.org/10.1200/JCO.2008.19.4860 PMID:19273702
Chang-jun, G. (2013). Risk factors of deep venous thrombosis after traumatic fracture. J N Pharm. 8, 99-100.
Cil, B. E., Canyiğit, M., Peynircioğlu, B., Hazirolan, T., Carkaci, S., Cekirge, S., & Balkanci, F. (2006). Subcutaneous venous port implantation in adult patients: A single center experience. Diagnostic and Interventional Radiology (Ankara, Turkey), 12(2), 93–98. PMID:16752357
Erden, F., Karagoz, H., Avci, A., Avci, D., Cetinkaya, A., Bahadir, S., & Erden, A. (2017a). Which one is best? platelet/lymphocyte ratio, neutrophil/lymphocyte ratio or both in determining deep venous thrombosis in behcet’s disease? Biomedical Research, •••, 28.
Erden, F., Karagoz, H., Avci, A., Avci, D., Cetinkaya, A., & Erden, A. (2017b). The values of mean platelet volume and the mean platelet volume/platelet ratio for predicting deep venous thrombosis in Behçet’s disease. LaboratoriumsMedizin-Journal of Laboratory Medicine, 41, 153–157.
Esfahani, H., Ghorbanpor, M., & Tanasan, A. (2016). Implantable Port Devices, Complications and outcome in Pediatric Cancer, a Retrospective Study. Iranian Journal of Pediatric Hematology and Oncology, 6(1), 1–8. PMID:27222696
Gandhi, R. T., Getrajdman, G. I., Brown, K. T., Gandras, E. J., Covey, A. M., Brody, L. A., & Khilnani, N. (2003). Placement of subcutaneous chest wall ports ipsilateral to axillary lymph node dissection. Journal of Vascular and Interventional Radiology, 14(8), 1063–1065. https://doi.org/10.1097/01.RVI.0000082863.05622.2A PMID:12902565
Huang, L., Li, J., & Jiang, Y. (2016). Association between hypertension and deep vein thrombosis after orthopedic surgery: A meta-analysis. European Journal of Medical Research, 21(1), 13. https://doi.org/10.1186/s40001-016-0207-z PMID:27004410
Ignatov, A., Hoffman, O., Smith, B., Fahlke, J., Peters, B., Bischoff, J., & Costa, S. D. (2009). An 11-year retrospective study of totally implanted central venous access ports: Complications and patient satisfaction. European Journal of Surgical Oncology, 35(3), 241–246. https://doi.org/10.1016/j.ejso.2008.01.020 PMID:18329836
Lip, G. Y. H. (2000). Hypertension and the prothrombotic state. Journal of Human Hypertension, 14(10-11), 687–690. https://doi.org/10.1038/sj.jhh.1001051 PMID:11095159
Morris, S. L., Jaques, P. F., & Mauro, M. A. (1992). Radiology-assisted placement of implantable subcutaneous infusion ports for long-term venous access. Radiology, 184(1), 149–151. https://doi.org/10.1148/radiology.184.1.1609072 PMID:1609072
Niederhuber, J. E., Ensminger, W., Gyves, J. W., Liepman, M., Doan, K., & Cozzi, E. (1982). Totally implanted venous and arterial access system to replace external catheters in cancer treatment. Surgery, 92(4), 706–712. PMID:7123491
Ogata, T., Yasaka, M., Wakugawa, Y., Kitazono, T., & Okada, Y. (2013). Association of deep venous thrombosis with calf vein diameter in acute hemorrhagic stroke. Journal of Stroke and Cerebrovascular Diseases, 22(7), 1002–1005. https://doi.org/10.1016/j.jstrokecerebrovasdis.2012.02.009 PMID:22424847
Samanc, T., Molinas Mandel, N., Bozkurt, A.K., Kutlu, F., and Uras, C. (2004). Evaluation of port complications in 115 cancer patients. Cerrahpaşa J Med 35, 71-77.
Spencer, C. G., Gurney, D., Blann, A. D., Beevers, D. G., & Lip, G. Y. H., & the ASCOT Steering Committee, Anglo-Scandinavian Cardiac Outcomes Trial. (2002). Von Willebrand factor, soluble P-selectin, and target organ damage in hypertension: A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). Hypertension, 40(1), 61–66. https://doi.org/10.1161/01.HYP.0000022061.12297.2E PMID:12105139
Stephens, L. C., Haire, W. D., Tarantolo, S., Reed, E., Schmit-Pokorny, K., Kessinger, A., & Klein, R. (1997). Normal saline versus heparin flush for maintaining central venous catheter patency during apheresis collection of peripheral blood stem cells (PBSC). Transfusion Science, 18(2), 187–193. https://doi.org/10.1016/S0955-3886(97)00008-8 PMID:10174683
Süslü, H., Arslan, G., & Tural, K. (2012). [Venous port implantation in adult patients: Retrospective evaluation]. The Journal of the Turkish Society of Algology, 24(1), 32–36. https://doi.org/10.5505/agri.2012.17362 PMID:22399126
Downloads
Published
Issue
Section
License
Copyright The Author(s) 2017. This article is published with open access by BioMedPress. This article is distributed under the terms of the Creative Commons Attribution License (CC-BY 4.0) which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
